William Blair reissued their market perform rating on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research report ...

Fintel reports that on April 1, 2025, William Blair upgraded their outlook for Nayax (NasdaqGS:NYAX) from Market Perform to ...

William Blair analyst Louie DiPalma says the U.S. Army changed course and put the Army Data Platform 2.0 program on indefinite hold. In 2023, ...

Shares of AI software company Palantir Technologies (PLTR) fell today, even after investment firm William Blair said that the ...

Equities research analysts at William Blair cut their Q4 2025 earnings per share estimates for Tetra Tech in a research note ...

Fintel reports that on March 26, 2025, William Blair initiated coverage of StoneX Group (NasdaqGS:SNEX) with a Outperform ...

Tesla shares fell more than 5% on Wednesday, ending the EV maker's blistering rebound out of a prolonged slump.

Lululemon stock fell 15% in afternoon trading after CEO Calvin McDonald said consumers are beginning to spend less in ...

Investing.com -- William Blair remains optimistic on Tesla (NASDAQ: TSLA) despite recent setbacks, forecasting that shares ...

Investing.com -- William Blair upgraded Palantir Technologies (NASDAQ:PLTR) to Market Perform following a 33% selloff from $125 to $84 over the past three weeks, despite concerns over its valuation.